Benitec Biopharma Ltd ADR Capital Reinvestment Ratio
Benitec Biopharma Ltd ADR capital reinvestment ratio. Benitec Biopharma Ltd ADR (BNTC) has a Capital Reinvestment Ratio of 0.00x as of September 2018, meaning it reinvests 0% of its operating cash flow ($5.87 Million) in capital expenditures ($26.00K). See how much free cash does Benitec Biopharma Ltd ADR generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Benitec Biopharma Ltd ADR (2019–2019)
Capital reinvestment ratio of Benitec Biopharma Ltd ADR from 2019 to 2019. This chart tracks Benitec Biopharma Ltd ADR's Capital Reinvestment Ratio across 1 annual periods. See Benitec Biopharma Ltd ADR financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Benitec Biopharma Ltd ADR Capital Reinvestment Ratio by Year (2019–2019)
Benitec Biopharma Ltd ADR capital reinvestment ratio by year from 2019 to 2019. For the full cash flow conversion analysis, see BNTC operating cash flow.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.08x | $4.79 Million | $403.40K | — |